Cytosorbents Corp
CTSO
33 hedge funds and large institutions have $8.52M invested in Cytosorbents Corp in 2015 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 5 increasing their positions, 9 reducing their positions, and 6 closing their positions.
322% more call options, than puts
Call options by funds: $1.48M | Put options by funds: $351K
33% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 6
12% more capital invested
Capital invested by funds: $7.63M → $8.52M (+$890K)
6% more funds holding
Funds holding: 31 → 33 (+2)
44% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
+$855K |
| 2 |
SC
Skylands Capital
Milwaukee,
Wisconsin
|
+$350K |
| 3 |
AIG
American International Group
New York
|
+$218K |
| 4 |
Goldman Sachs
New York
|
+$128K |
| 5 |
FAM
Fortaleza Asset Management
Chicago,
Illinois
|
+$102K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$761K |
| 2 |
AQR Capital Management
Greenwich,
Connecticut
|
-$152K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$93.2K |
| 4 |
TCM
Tufton Capital Management
Hunt Valley,
Maryland
|
-$74K |
| 5 |
ES
Equitec Specialists
Chicago,
Illinois
|
-$45K |
CTSO Hedge Fund Activity: Q3 2015 in Review
33 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Cytosorbents Corp (CTSO) for Q3 2015, worth a combined $8.52M — up 12% from $7.63M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new CTSO positions and 6 closed out — a net gain of 2 holders — while 5 added to existing stakes and 9 trimmed.
The largest buyer was Raymond James & Associates, opening a new position worth an estimated $855K. The largest seller was Morgan Stanley, cutting an estimated $761K.
- 33 institutional investors held Cytosorbents Corp (CTSO) as of Q3 2015, up from 31 in Q2 2015.
- Funds reported $8.52M of Cytosorbents Corp stock for Q3 2015, up 12% quarter-over-quarter.
- 8 funds opened new Cytosorbents Corp positions in Q3 2015 and 6 closed out, a net change of +2 holders.
- The largest Cytosorbents Corp buyer in Q3 2015 was Raymond James & Associates, an estimated $855K added.
- The largest Cytosorbents Corp seller in Q3 2015 was Morgan Stanley, an estimated $761K sold.
Based on aggregated 13F filings for Q3 2015.